✦ LIBER ✦

Novel new noninvasive biomarkers of inflammatory bowel disease

✍ Scribed by Shailendra Kapoor

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 44 KB
Volume: 14
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.20440

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Review of Fecal Biomarkers in Inflammato

Review of Fecal Biomarkers in Inflammatory Bowel Disease

✍ Andrew D. Sutherland; Richard B. Gearry; Frank A. Frizelle 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 175 KB

New proteomic approaches for biomarker d

New proteomic approaches for biomarker discovery in inflammatory bowel disease

✍ Giulia Roda; Alessandra Caponi; Marco Benevento; Paolo Nanni; Laura Mezzanotte; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 1 views

There is an increasing interest in the discovery of new inflammatory bowel disease (IBD) biomarkers able to predict the future patterns of disease and to help in diagnosis, treatment, and prognosis. A biomarker is a substance that can be measured biologically and is associated with an increased risk

Novel pathophysiological concepts of inf

Novel pathophysiological concepts of inflammatory bowel disease

✍ Toshifumi Hibi; Haruhiko Ogata 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 622 KB

Pilot study using PET/CT as a novel, non

Pilot study using PET/CT as a novel, noninvasive assessment of disease activity in inflammatory bowel disease

✍ Randall S. Meisner; Bret J. Spier; Sigurdur Einarsson; Erica N. Roberson; Scott 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB

Background: A pilot study was performed investigating the possibility that positron emission tomography (PET) activity using 18-fluorodeoxyglucose (FDG) with nearly simultaneous computerized tomography (CT) for anatomic accuracy would identify regions of active inflammation in both ulcerative coliti

New steroids for inflammatory bowel dise

New steroids for inflammatory bowel disease

✍ Dr. Robert Löfberg 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 700 KB

The antiinflammatory effects of glucocorticosteroids (GCS) in inflammatory bowel disease (IBD) are unsurpassed by those of any other type of drug, but the beneficial effects are often offset by troublesome, and sometimes irreversible, systemic side effects. Improved GCS have been developed with the

Serum biomarkers in a mouse model of bac

Serum biomarkers in a mouse model of bacterial-induced inflammatory bowel disease

✍ Anne E. Torrence; Thea Brabb; Joanne L. Viney; Helle Bielefeldt-Ohmann; Piper Tr 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 2 views

## Background: The diagnosis and classification of inflammatory bowel disease (IBD) require both clinical and histopathologic data. Serum biomarkers would be of considerable benefit to noninvasively monitor the progression of disease, assess effectiveness of therapies, and assist in understanding d